rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
9
|
pubmed:dateCreated |
2005-5-3
|
pubmed:abstractText |
To test the ability of a reverse transcriptase-PCR (RT-PCR) assay, based on gene expression profiles, to accurately determine the risk of recurrence in patients with node-negative breast cancer who did not receive systemic therapy using formalin-fixed, paraffin-embedded tissue. A secondary objective was to determine whether the quantitative RT-PCR data correlated with immunohistochemistry assay data regarding estrogen receptor, progesterone receptor, and human epidermal growth factor receptor 2 status.
|
pubmed:grant |
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
May
|
pubmed:issn |
1078-0432
|
pubmed:author |
pubmed-author:BakerJoffreJ,
pubmed-author:CoombesKevinK,
pubmed-author:CristofanilliMassimoM,
pubmed-author:CroninMaureenM,
pubmed-author:EstevaFrancisco JFJ,
pubmed-author:HortobagyiGabriel NGN,
pubmed-author:LeeSang-JoonSJ,
pubmed-author:SahinAysegul AAA,
pubmed-author:ShakStevenS,
pubmed-author:WalkerMichaelM,
pubmed-author:WatsonDrewD
|
pubmed:issnType |
Print
|
pubmed:day |
1
|
pubmed:volume |
11
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
3315-9
|
pubmed:dateRevised |
2009-11-19
|
pubmed:meshHeading |
pubmed-meshheading:15867229-Adult,
pubmed-meshheading:15867229-Aged,
pubmed-meshheading:15867229-Antineoplastic Agents, Hormonal,
pubmed-meshheading:15867229-Breast Neoplasms,
pubmed-meshheading:15867229-Chemotherapy, Adjuvant,
pubmed-meshheading:15867229-Cluster Analysis,
pubmed-meshheading:15867229-Female,
pubmed-meshheading:15867229-Follow-Up Studies,
pubmed-meshheading:15867229-Gene Expression Profiling,
pubmed-meshheading:15867229-Gene Expression Regulation, Neoplastic,
pubmed-meshheading:15867229-Humans,
pubmed-meshheading:15867229-Immunohistochemistry,
pubmed-meshheading:15867229-Ki-67 Antigen,
pubmed-meshheading:15867229-Lymphatic Metastasis,
pubmed-meshheading:15867229-Middle Aged,
pubmed-meshheading:15867229-Neoplasm Recurrence, Local,
pubmed-meshheading:15867229-Prognosis,
pubmed-meshheading:15867229-Receptor, erbB-2,
pubmed-meshheading:15867229-Receptors, Estrogen,
pubmed-meshheading:15867229-Receptors, Progesterone,
pubmed-meshheading:15867229-Reverse Transcriptase Polymerase Chain Reaction,
pubmed-meshheading:15867229-Survival Analysis,
pubmed-meshheading:15867229-Tamoxifen
|
pubmed:year |
2005
|
pubmed:articleTitle |
Prognostic role of a multigene reverse transcriptase-PCR assay in patients with node-negative breast cancer not receiving adjuvant systemic therapy.
|
pubmed:affiliation |
Department of Breast Medical Oncology, The University of Texas M.D. Anderson Cancer Center, Houston, Texas 77030, USA. festeva@mdanderson.org
|
pubmed:publicationType |
Journal Article,
Comparative Study,
Research Support, U.S. Gov't, P.H.S.,
Research Support, Non-U.S. Gov't,
Research Support, N.I.H., Extramural
|